According to Lipella Pharmaceuticals's latest financial reports the company has $3.29 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $3.29 M | -35.69% |
2022-12-31 | $5.12 M | 198.75% |
2021-12-31 | $1.71 M | 182.56% |
2020-12-31 | $0.6 M |